Centessa Pharmaceuticals plc
Centessa Pharmaceuticals plc (CNTA) is known on NASDAQ - United Kingdom, but Bullrun does not have financial statement history attached to this listing yet.
Key Metrics
- TickerCNTA
- ExchangeNASDAQ
- CountryUnited Kingdom
- SectorHealthcare
- IndustryBiotechnology
- CurrencyUSD
- Financial periodQ1 2026
- RevenueUSD 0
- Net income-USD 250.64M
- Free cash flow-USD 209.17M